Learn

Psoriasis and Gut Health: What the Evidence Actually Shows

Last revised 2026-09-05

The short answer

There is a real, repeatedly measured relationship between the gut and psoriasis. It is not folklore, and it is not fringe — but it is narrower and messier than most of what you will read about it.

Three things hold up:

The psoriatic gut behaves abnormally. Not always in the same species, but almost always in the same direction — less microbial diversity, less butyrate, fewer anti-inflammatory metabolites.
The gut barrier is measurably leakier in psoriasis than in people without it, and there is a mechanism connecting that leak to the exact immune pathway that drives plaques.
Interventions aimed at the gut have moved skin scores in randomised trials. Small trials. But real ones, with the standard severity endpoint dermatologists use.

Three things do not hold up, and you should be suspicious of anyone who tells you otherwise:

There is no single "psoriasis bacterium" to kill or to buy.
No trial has shown that fixing the gut clears psoriasis on its own.
A stool test cannot currently tell you whether your gut is causing your skin disease.

Heal Psoriasis devotes Chapter 10 to this, and it is one of the chapters where the book is at its most careful — it explicitly says the species-level picture is inconsistent and says so before it says anything else.

What actually replicates

The most consistent finding is a shift in the ratio between the two largest bacterial groups in the gut. Chapter 10 cites a 2020 study of 55 psoriasis patients in which the Firmicutes-to-Bacteroidetes ratio averaged 1.29, against 0.63 in healthy controls, and notes that multiple independent reviews have found the same pattern.

That ratio matters because of what it changes downstream. Tip the balance toward Firmicutes and the whole ecosystem's metabolic output shifts — in particular, it produces less of the short-chain fatty acids the immune system depends on.

Below that level, the picture falls apart. Chapter 10 cites a 2020 PRISMA systematic review that concluded gut microbiome alterations in psoriasis are real and reproducible, but that the specific species involved vary between studies. Some studies find a given beneficial species depleted; others find the same species elevated. Geography, diet and medication all move the numbers.

The book's own summary of this is worth repeating, because it is the opposite of how most gut content is written: the functional output is abnormal in nearly every study, even where the species are not. Fewer anti-inflammatory metabolites. Less butyrate. Less diversity.

Why a gut problem shows up on your skin

Two mechanisms, both well characterised.

Butyrate, Tregs, and the missing brake

When gut bacteria ferment fibre they produce butyrate. Chapter 10 traces the chain: butyrate acts as an HDAC inhibitor, opening up the region of DNA that encodes FOXP3 — the master switch that turns a generic immune cell into a regulatory T cell (Treg). Tregs are the cells that shut inflammation down once a threat has been handled.

In 2021, researchers isolated Tregs from psoriasis patients and found they had reduced suppressive activity compared with Tregs from healthy people. The cells were present; they were not doing the job. Adding sodium butyrate restored their function, raised FOXP3 and IL-10, and lowered IL-17 — the primary driver of psoriasis. The authors concluded that short-chain fatty acids "harbor therapeutic potential for psoriasis by restoring Treg function."

So: less fibre reaching the right bacteria means less butyrate, which means fewer functional Tregs, which means the Th17 side of the immune system runs without a brake.

The barrier, zonulin, and LPS

Your intestinal lining is one cell thick, held together by protein bridges called tight junctions. When those junctions open too far — intestinal hyperpermeability, the thing usually called leaky gut — molecules cross that should not.

The one that matters most is lipopolysaccharide (LPS), a component of certain bacterial cell walls and one of the most potent activators of the innate immune system. Chapter 10 describes what happens next: LPS in the bloodstream activates TLR4 on immune cells throughout the body, setting off IL-6, TNF-alpha and IL-23 — the cytokines that drive psoriasis.

Alessio Fasano's work at Harvard identified zonulin as the molecule that controls how far those tight junctions open. The two best-documented zonulin triggers are certain bacteria and, in genetically susceptible people, gluten.

Chapter 10 also notes that psoriasis patients show elevated markers of intestinal permeability and bacterial translocation compared with controls — this part is measured in people, not inferred from mice.

What the trials show

This is the section most gut-health articles skip, because the honest version is less impressive than the mechanism.

Probiotics. Chapter 10 cites Navarro-López and colleagues (2019), a randomised placebo-controlled trial of 90 adults with plaque psoriasis given a Bifidobacterium longum/B. lactis/Lactobacillus rhamnosus mix for 12 weeks. In that trial, 66.7% of the probiotic group reached PASI 75 — a 75% improvement in severity — against 41.9% on placebo, with a lower relapse rate at six months.

One trial. Ninety people. Twelve weeks. It is a genuine signal, and it is nowhere near enough to justify how probiotics are sold.

Diet. The NutriNet-Santé cohort followed more than 35,000 people and found higher adherence to a Mediterranean pattern associated with 29% lower odds of severe psoriasis. A 2025 randomised trial of the Mediterranean diet in psoriasis reported 47.4% of the diet group reaching PASI 75 against 0% in the control group over 16 weeks.

Fermented foods. The Stanford study published in Cell in 2021 ran 17 weeks: a high-fermented-food diet steadily increased gut microbial diversity and decreased 19 inflammatory markers, including IL-6. A high-fibre diet did not increase diversity over the same period, though it did raise short-chain fatty acid production. That study was not in psoriasis patients — it is mechanism, not outcome.

The book's own conclusion from all this is blunt and correct: don't bother with probiotics if you aren't willing to correct your diet first.

The gluten question — and the test you have to do first

This is where most advice goes wrong.

Chapter 10 cites a 2000 study in which 73% of psoriasis patients who tested positive for anti-gliadin antibodies improved on a gluten-free diet, with significant severity reduction over three months. A follow-up found the gluten-free diet reduced proliferating cells in psoriatic skin.

Then the number that matters: one study found elevated IgA antibodies to gliadin in 14% of psoriasis patients, against 2% of controls. The book says the quiet part out loud — for the other 86%, removing gluten may offer no benefit at all. A blood test tells you which group you are in.

One thing the book does not warn you about, and it is important: coeliac and gliadin antibody blood tests only work while you are still eating gluten. Go gluten-free first and the tests can come back falsely negative, and you will have to eat gluten again for weeks to get a usable result. Chapter 3 puts coeliac odds in psoriasis at over double the general population, and Chapter 18's Phase 1 removes gluten — but the book never joins those two facts together. Test before you eliminate, not after. This point is ours, not the book's; it is listed on the corrections page.

What damaged the gut in the first place

Chapter 10's list, briefly:

The Western diet. In a 2020 UC Davis experiment, mice genetically predisposed to psoriasis developed psoriasiform skin inflammation within four weeks of a high-fat, low-fibre diet — before they had gained significant weight. Their gut bacteria shifted within days and IL-17A-producing cells migrated from gut to skin.
Ultra-processed food. Emulsifiers, artificial sweeteners and additives damage the barrier and reduce diversity independent of calories.
Antibiotics. A single broad-spectrum course can cut gut bacterial diversity by 25–50%.
Environmental toxins. Glyphosate inhibits the shikimate pathway, which human cells do not have and gut bacteria do — killing beneficial species selectively while leaving resistant pathogens alone.
Chronic stress, through the vagus nerve and cortisol, changing motility, blood flow, the mucus layer and bacterial populations.

None of these acts alone. That is the actual argument.

What the book asks you to do

Chapter 10 uses the 5R framework — Remove, Replace, Reinoculate, Repair, Rebalance. In short: remove the dietary and environmental damage; support digestion; reintroduce bacteria through both supplements and fermented food; repair the lining (the chapter cites a trial of L-glutamine at 5g three times daily restoring barrier function in 79.6% of participants against 5.8% on placebo, and zinc carnosine at 37.5mg twice daily preventing an NSAID-induced rise in permeability); then rebalance sleep, stress and movement.

The timeframe the book gives is the part people skip: full gut ecosystem restoration takes 6–12 months of consistent effort. Not weeks.

One line in that chapter deserves emphasis because it is a safety point, not a nutrition point. NSAIDs and proton pump inhibitors both affect the gut — but the book is explicit that this does not mean stopping medication without guidance. It means having an informed conversation with the person who prescribed it. That is the right instruction and it applies to everything on this page.

The honest limits

Association is not direction. Almost all the human microbiome data in psoriasis is cross-sectional. Sick guts and sick skin travel together; which one moved first is largely unestablished.
The trials are small. One 90-person probiotic RCT is a starting point, not a body of evidence.
Nobody has tested the whole thing. There is no trial of the book's full gut protocol. The book does not claim there is.
Stool tests do not currently diagnose this. They can be interesting. They are not conclusive, and they are expensive.
A gut protocol is not a substitute for treatment. If you are on a biologic, methotrexate, a steroid or anything else prescribed, keep taking it as prescribed. Chapter 18 is unambiguous that stopping a biologic to try a lifestyle protocol can produce a rebound worse than the disease you started with, and any change to that is a conversation with your dermatologist — not a decision you make after reading an article.

Where to start

If you want to find out whether your gut and your skin are actually moving together — rather than assuming it — the free Gut–Skin Diary logs both daily and withholds any pattern until you have fourteen days of data, because anything shorter is noise. The free Root Cause Profile is the wider version: it scores where the pressure is across several domains, so you find out whether the gut is even your dominant problem before you spend a year on it.

If you want the test list to take to an appointment — including the anti-gliadin antibody test this article argues you should do before eliminating anything — the free Blood Work Guide builds it for you.

And if you want the full mechanism with every citation, that is Chapter 10 of **Heal Psoriasis**, along with Chapter 9 on the environmental exposures that damage the gut and Chapter 13 on the fats the resolution system runs on.

This article is educational information, not medical advice. It does not diagnose, treat, or replace care from a clinician who knows your history. Never start, stop, or change a prescribed medication based on anything you read here — talk to your doctor first. Individual results vary.